Michael Friedman

About

Michael Friedman is a pioneering surgeon whose work has fundamentally reshaped the surgical management of obstructive sleep apnea (OSA). His primary research focus is the application of transoral robotic surgery (TORS) for OSA, a field he helped establish. Friedman’s landmark 2012 paper, "Transoral Robotic Glossectomy for the Treatment of Obstructive Sleep Apnea‐Hypopnea Syndrome," with 145 citations, demonstrated the feasibility of performing a robotic partial glossectomy without the need for a routine tracheotomy—a major advancement that dramatically reduced patient morbidity. This work laid the foundation for a less invasive, more effective surgical approach. His subsequent studies have continued to explore the broader health impacts of TORS-OSA surgery, including its effects on cardiovascular risk factors like homocysteine levels and its surprising benefits on lower urinary tract symptoms and nocturia in male patients. By consistently pushing the boundaries of what is possible with robotic surgery, Friedman has not only provided a powerful new tool for treating severe OSA but has also illuminated the systemic health improvements that can follow successful airway surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Transoral Robotic Glossectomy for the Treatment of Obstructive Sleep Apnea‐Hypopnea Syndrome

   145 citations · 2012
2. 2
   Transoral robotic OSA surgery

   19 citations · 2020
3. 3
   Homocysteine Levels in Severe OSA Patients Before and After TORS‐OSA Surgery

   9 citations · 2023
4. 4
   Robotic glossectomy for obstructive sleep apnea technique

   4 citations · 2013
5. 5
   Effects of TORS-OSA Surgery on Lower Urinary Tract Symptoms, Overactive Bladder Symptoms, and Nocturia in Male Patients with Obstructive Sleep Apnea/Hypopnea Syndrome

   4 citations · 2022

Key Collaborators

Contact & Links